Dr. Nayyar Syed, MD
What this data tells you about Dr. Syed
Dr. Nayyar Syed is an internal medicine specialist in Pittsburg, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Syed performed 154,519 Medicare services across 4,293 unique beneficiaries.
Between the years covered by Open Payments, Dr. Syed received a total of $4,728 from 53 pharmaceutical and/or device companies across 224 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Syed is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron sucrose injection (Venofer) | 63,400 | $0 | $2 |
| Anti-nausea injection (fosaprepitant) | 24,000 | $0 | $5 |
| Pembrolizumab injection (Keytruda) | 15,200 | $43 | $136 |
| Paclitaxel chemotherapy injection | 11,822 | $0 | $8 |
| Iron infusion (Feraheme) | 10,710 | $0 | $5 |
| Darbepoetin injection (Aranesp) for anemia | 7,820 | $2 | $20 |
| Dexamethasone injection (steroid) | 4,446 | $0 | $1 |
| Denosumab injection (Prolia/Xgeva) | 2,040 | $18 | $67 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,850 | $1 | $114 |
| Injection, granisetron hydrochloride, 100 mcg | 1,780 | $0 | $24 |
| Blood draw (venipuncture) | 1,473 | $8 | $20 |
| Complete blood count (CBC) with differential | 1,471 | $8 | $36 |
| Comprehensive metabolic blood panel | 1,373 | $10 | $64 |
| Office visit, established patient (20-29 min) | 1,054 | $63 | $250 |
| Injection of additional new drug or substance into vein | 1,036 | $12 | $108 |
| Injection, fluorouracil, 500 mg | 574 | $2 | $13 |
| Administration of chemotherapy into vein, 1 hour or less | 534 | $97 | $707 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 407 | $46 | $313 |
| Office visit, established patient (30-39 min) | 283 | $92 | $368 |
| Drug injection, under skin or into muscle | 231 | $10 | $96 |
| Administration of chemotherapy into vein, each additional hour | 222 | $21 | $161 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 208 | $22 | $157 |
| Injection, diphenhydramine hcl, up to 50 mg | 185 | $1 | $7 |
| Injection, zoledronic acid, 1 mg | 185 | $7 | $431 |
| Ferritin level test (iron stores) | 162 | $13 | $60 |
| Iron level test | 162 | $6 | $27 |
| Iron binding capacity test | 162 | $9 | $35 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 156 | $54 | $211 |
| Microscopic examination for white blood cells with manual cell count | 154 | $4 | $22 |
| Complete blood count (CBC), automated | 154 | $6 | $34 |
| Administration of additional new drug or substance into vein, 1 hour or less | 142 | $48 | $344 |
| Unclassified drugs | 110 | $1 | $8 |
| Irrigation of implanted venous access drug delivery device | 95 | $17 | $114 |
| New patient office visit (30-44 min) | 89 | $78 | $372 |
| Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services | 84 | $73 | $70 |
| Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l | 81 | $124 | $500 |
| Injection of drug or substance into vein | 73 | $28 | $247 |
| New patient office visit (45-59 min) | 72 | $121 | $565 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 68 | $24 | $145 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 65 | $133 | $3,675 |
| Magnesium level test | 59 | $7 | $29 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 59 | $1 | $19 |
| Drawing of blood for a medical problem | 57 | $59 | $264 |
| Administration of additional new drug or substance into vein using push technique | 51 | $42 | $289 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 48 | $16 | $100 |
| Infusion into a vein for hydration, each additional hour | 30 | $10 | $75 |
| Reticulated (young) platelet measurement | 24 | $35 | $143 |
| Injection, methylprednisolone sodium succinate, up to 125 mg | 22 | $4 | $25 |
| Infusion, normal saline solution , 1000 cc | 22 | $2 | $19 |
| Infusion into a vein for hydration, 31-60 minutes | 14 | $25 | $256 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (82%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Syed is a mixed practice specialist, with above-average Medicare volume (top 0% in TX), with low-engagement industry engagement in the top 17% of TX peers, with 19 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Syed experienced with iron sucrose injection (venofer)?
Does Dr. Syed receive payments from pharmaceutical companies?
How do Dr. Syed's costs compare to other internal medicine physicians in Pittsburg?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology